The SUPPLY Act establishes a federal program to insure second loans (additional financing) for building accessory dwelling units (ADUs) on single-family properties. This insurance, administered by the Department of Housing and Urban Development, covers up to 30% of a standard one-unit home loan amount or 100% of the property value after construction (with potential increases based on 50% of projected rental income). Homeowners seeking to add ADUs - such as backyard cottages, converted basements, or detached units - can use this insurance to secure financing, with a government premium of up to 1% annually. The bill also requires Fannie Mae and Freddie Mac to purchase and securitize these insured loans, potentially expanding access to ADU financing.
The Jobs in the Woods Act establishes a federal grant program to fund career training in forestry operations and products industries. It provides competitive grants (ranging from $500,000 to $2 million over up to 4 years) to eligible entities like nonprofits, states, tribes, or community colleges in targeted rural areas. These areas must be nonmetropolitan low-income communities, have broadband access, or have populations under 50,000. Grants require applicants to demonstrate regional need, plan for program sustainability, partner with schools, and address aging workforces or youth migration. The program is funded at $10 million annually from 2026 through 2030.
This bill requires the Department of Veterans Affairs (VA) to display clear warnings on all public-facing VA websites and online tools about predatory practices. Specifically, it mandates that VA websites warn veterans not to share their account login credentials or bank account information (like usernames/passwords) with anyone. The law amends existing VA procedures to add this security warning as a standard message during website logins. The Chief Veterans Experience Officer will implement these changes, effective 180 days after the bill's enactment. The policy directly affects veterans using VA online services by strengthening protections against fraudulent agents targeting their personal information.
S 2316, the Cooper Davis and Devin Norring Act, requires electronic communication service providers and remote computing services to report to the Attorney General when they have actual knowledge of certain drug-related crimes involving fentanyl, methamphetamine, counterfeit prescription drugs, or unauthorized prescription medications. Providers must submit detailed reports within 60 days, including account information and relevant data about the crime, but not the content of communications. The bill imposes civil penalties of up to $190,000 for failing to report and $100,000 for submitting false reports, while protecting providers from being required to monitor content or scan for violations. It exempts broadband internet and text messaging service providers from these requirements and mandates annual reports from the Attorney General on the number and outcomes of submitted reports. The law aims to improve law enforcement's ability to address drug trafficking while maintaining privacy protections for users.
This bill requires the Health and Human Services (HHS) Secretary to update all HHS grant program regulations and guidance related to opioid misuse to include *all* FDA-approved opioid overdose reversal drugs - not just naloxone. It specifically targets two key grant programs: the State Opioid Response Grants (under the 21st Century Cures Act) and the Tribal Opioid Response Grants, plus the Public Health Service Act's grant program for regional/national substance use disorder prevention. HHS must update existing references within one year of the bill's enactment to ensure grants cover any approved reversal drug. This directly affects states, tribes, and community organizations receiving these federal grants for opioid response programs.
The ALERT Communities Act (S 2332) provides federal funding to help states and tribes distribute fentanyl and xylazine test strips to prevent overdose deaths, directly affecting communities and healthcare providers working on opioid crises. It expands grant programs under the 21st Century Cures Act to cover test strips, requires first responder training on using them, and mandates the development of research frameworks for improving test strip technology. The bill also directs the Health Secretary to study how test strip availability impacts overdose rates and treatment engagement, with a report due to Congress within two years. These provisions aim to make overdose prevention tools more accessible through concrete policy changes.
This bill creates a federal grant program to help schools recruit and retain paraprofessionals - school support staff like teaching assistants - who work directly with students but lack full teaching credentials. It allocates funds to states based on prior Title I education funding, requiring states to prioritize schools serving high numbers of low-income students or designated "high-need" schools. Funds can be used for mentoring programs, professional development, credentialing (like special education or English learner certificates), and wage increases or bonuses for paraprofessionals. The program mandates annual reporting on wage baselines, paraprofessional numbers, and how funds were used to address shortages.
The Price Gouging Prevention Act of 2025 prohibits selling goods or services at grossly excessive prices during exceptional market shocks like natural disasters, energy shortages, or public health emergencies. It creates a presumption of violation when companies with "unfair leverage" (revenue over $1 billion, dominant market position, or other factors) increase prices beyond normal market fluctuations. The law requires public companies to disclose detailed pricing information in SEC filings during these emergencies, including explanations for price increases and how costs affected pricing. The Federal Trade Commission and state attorneys general would enforce the law, with civil penalties up to 5% of a company's revenue for violations. The bill also appropriates $1 billion to fund FTC enforcement efforts.
This bill establishes a program to insure second mortgages (loans taken out after the primary mortgage) for financing accessory dwelling units (ADUs) on single-family properties. The Secretary of Housing and Urban Development must create the program within two years, setting loan limits (up to 30% of a standard mortgage amount or 100% of the property's after-construction value, with potential increases based on 50% of projected rental income) and requiring borrowers to own the property and apply for insurance. It also allows Fannie Mae and Freddie Mac to purchase and securitize these insured loans, unless the Federal Housing Finance Agency determines market risks require a prohibition. The program requires the Secretary to submit annual reports to Congress on its implementation starting one year after enactment.
HR 4477, the PRICE Act, creates a new federal grant program to improve affordable manufactured housing communities. It provides funds for infrastructure, repairs, safety upgrades, and community services in communities that are affordable to low- and moderate-income residents (at or below 120% of area median income) and either owned by residents or committed to remaining affordable. Eligible projects include replacing homes (excluding pre-1976 units), weatherization, accessibility modifications, and resident services like eviction prevention. The program prioritizes projects that preserve long-term affordability for low-income residents and is open to community groups, local governments, tribes, and nonprofit housing organizations.
Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act This act permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Under the act, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term). Additionally, the act establishes a new, alternative registration process for certain schedule I research. The act also makes several other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration. Finally, the act expresses the sense that Congress agrees with the interpretation of the Controlled Substances Act in United States v. McCray , a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance.
The Palliative Care and Hospice Education and Training Act creates federal funding programs to improve training for health professionals in palliative and hospice care. It authorizes $15 million annually for 2026-2030 to support grants for education programs that train doctors, nurses, social workers, and other health professionals in palliative care. The bill prioritizes programs serving rural or medically underserved areas, pediatric patients, and racial/ethnic minority populations. It establishes specific training requirements including interprofessional team-based care, patient and family engagement, and integration with primary care settings. The legislation also includes provisions to disseminate information about palliative care benefits to patients, families, and health professionals.
